Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 6.8 kDa mitochondrial proteolipid pseudogene (ENSG00000254492, also known as LOC112268018) is classified as a processed pseudogene. While its name is derived from a protein-coding ancestor gene that encodes a small mitochondrial proteolipid, this locus itself does not produce a functional protein product. Pseudogenes are remnants of genes that have lost their protein-coding potential due to disabling mutations or truncation; processed pseudogenes, in particular, arise via mRNA retrotransposition and may occasionally be transcribed but are typically non-functional. There is no evidence supporting its role as a therapeutic target, nor is there support for its involvement in specific diseases or drug action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 6.8 kDa mitochondrial proteolipid pseudogene.